S&P 500 7718.60 -0.38%
NASDAQ 26506.99 -0.29%
TASI 11024.73 -0.40%
Oil (WTI) 91.48 +0.00%
Oil (Brent) 96.28 +0.00%
VIX 15.30 +5.30%
Gold 4476.60 +0.00%
USD/SAR 3.76 +0.02%

Elevance Health, Inc.

ELV · Healthcare · · USD
407.50 USD
0.00 (-1.76%)
● Updated 2026-09-07 20:34 Saudi Time ↻ Refresh
Short-term Mid-term Long-term

Fahodi Score BUY Mid-term (Position)

76
/ 100
Technical 100
Trend & RS 73
Momentum 72
Fundamental 80
Macro 64
Liquidity 50
ComponentScoreWeight
Technical 100.0 20%
Trend & RS 73.0 30%
Momentum 72.2 15%
Fundamental 80.4 10%
Macro 64.4 20%
Liquidity 49.9 5%

Trade Setup

Entry 407.50
Stop Loss 388.00 (4.8%)
Target 1 (1:1) 427.00 (+4.8%)
Target 2 (2:1) 446.50 (+9.6%)
ATR(14) 9.75 (2.4%)
Risk per Share 19.50
Reward:Risk 2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor Score Z Bar
Value 75.9 +1.03
Momentum 72.2 +0.89
Quality 32.1 -0.72
Composite 60.1

Quality Scores

Piotroski F-Score 7 /9 — Strong
✓ ✓ ✗ ✗ ✓ ✓ ✓ ✓ ✓
1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover
Altman Z-Score 4.15 — Safe Zone
Distress <1.81Grey 1.81–2.99>2.99 Safe

Valuation vs Peers Undervalued

MetricStockSectorvs Peers
P/E Ratio 18.0 22.0 -18% below
P/B Ratio 2.0 4.0 Below
Dividend Yield 1.7% 1.5% Above avg

Comparing against Healthcare median multiples.

Trading at a discount to sector peers — potential value opportunity.

Intrinsic Value (DCF) Significantly Overvalued

Intrinsic Value
279.24
vs
Market Price
407.50
Upside
-31.5%
Margin of Safety -45.9%
Stage 1 PV (5yr FCF)16,150,396,807
Terminal Value PV44,407,827,064
Total Enterprise Value60,558,223,871

Assumptions

Base FCF3,924,466,672
Growth Rate (5yr)2.0%
Terminal Growth2.5%
Discount Rate (WACC)9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.5%
Recommended Size
49.32%
Full Kelly
24.66%
Half Kelly
5.0%
Max Cap (Moderate)

Kelly inputs derived from quant score 76/100. Estimated win rate 63%, avg win 9.6%, avg loss 3.5%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary STRONG BUY

4
Bullish Signals
0
Bearish Signals
56.63
RSI(14)
3.7998
MACD

Relative Strength (RS) NEUTRAL

57
/ 99
RS Rating
O'Neil filter: <80
RS vs SPY → FLAT (-6.2% vs SPY 3M)
RS vs Sector UNDERPERFORMING (Healthcare)
RS New High No (61d since high)
Sector Outperformance -9.3% (3M)
RS Line — stock / SPY (90 bars)
← older newer →
RS vs SPY 50-day SMA of RS
NEUTRAL: In line with the market — no strong outperformance or underperformance.

Technical Indicators

IndicatorValueSignal
Rsi 56.63 NEUTRAL
Macd 3.7998 BULLISH
Ma Cross 396.29 / 357.42 GOLDEN CROSS
Trend Short ABOVE SMA50
Trend Long ABOVE SMA200
Bollinger MIDDLE
Volume 1.29x NORMAL

Key Levels

LevelPrice
52-Week High436.24
Bollinger Upper411.08
SMA(200)357.42
SMA(50)396.29
SMA(20)399.54
Current Price407.50
Bollinger Lower388.0
52-Week Low274.84
ATR(14)9.75

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

DISTRIBUTION C Confidence
64%
Volume Dry-Up (Accumulation) Upthrust (potential)
Acc: 2.0  |  Dist: 3.5  |  Markup: 0.0  |  Markdown: 0.0

Volume Spread Analysis (last 5 bars)

DateSignalVolDescription
2026-08-31 Normal 1.24x Normal bar — no special VSA pattern
2026-09-01 Normal 1.25x Normal bar — no special VSA pattern
2026-09-02 Normal 1.12x Normal bar — no special VSA pattern
2026-09-03 Normal 1.39x Normal bar — no special VSA pattern
2026-09-04 Normal 1.29x Normal bar — no special VSA pattern

Ichimoku Cloud BULLISH

LineValueStatus
Tenkan-sen (9) 403.69 Above Kijun
Kijun-sen (26) 393.52 Base line
Senkou A 398.61 Leading span A
Senkou B 399.61 Leading span B
Cloud 398.61 – 399.61 Bearish (Red)
Price vs Cloud 407.50 Above Cloud
Chikou Span 375.84 Bullish
Alignment Score 3/4 BULLISH

TTM Squeeze & Divergences

TTM Squeeze

SQUEEZE ON 6 bars Momentum: BULLISH FADING
BB: 388.0 – 411.08  |  KC: 385.95 – 413.13

Divergences (last 60 bars)

TypeIndicatorBars AgoStrength
Hidden Bullish RSI 5

Anchored VWAP

VWAP: 364.04 Anchor: 2026-03-09 (52w Low) ABOVE AVWAP +11.9%

Heikin-Ashi Trend

BULLISH Full data via /api/advanced/ELV

Valuation

MetricValue
Market Cap88.37B
P/E (TTM)18.02
Forward P/EN/A
P/B1.97
EPS22.62

Financial Health

MetricValue
Revenue Growth1.4%
Profit Margin2.5%
ROE11.1%
Debt/Equity68.95
Current Ratio1.52
Dividend Yield1.7%
Payout RatioN/A
Beta0.70

Trading Data

407.50
Open
407.50
Day High
407.50
Day Low
1.04M
Volume (0.8x avg)

Recent News (8)

Insurers Have Already Told Wall Street Which Advantage Plans Die on December 31. Members Are the Last to Know, and the Letter Isn’t Due Until October 2.
24/7 Wall St. · 2026-09-05
Elevance Health (ELV) Stock Still Looks Undervalued Despite Its 37% Run
Simply Wall St. · 2026-09-04
UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy?
Zacks · 2026-09-04
UnitedHealth Stock Recovered Before Its Margins Did
Trefis · 2026-09-03
Is UnitedHealth Finally Turning the Corner After a Tough 2025?
Zacks · 2026-09-03
CVS Stock Has Left Its Peers Behind. Or Has It?
Trefis · 2026-09-03
Centene Stock Roars Back 117% in a Year: Is CNC Still a Buy?
Zacks · 2026-09-02
How Is Elevance Health’s Stock Performance Compared to Other Health Providers?
Barchart · 2026-09-02

Price Chart (90 Days)

Candlesticks (green=up, red=down) SMA 20 SMA 50 Bollinger Bands (upper/lower) Volume (green=buying, red=selling)
Powered by Fahodi Methodology. This is analytical output, not financial advice. Always do your own due diligence.  ·  Pipeline status  ·  Data: —